Mindfully Adherent is a pilot project supported by the San Antonio Life Sciences Institute (SALSI) designed to increase buprenorphine adherence in those suffering from opioid use disorder. Buprenorphine is an evidence-based medication used as a treatment for those struggling with opioid use disorder. Adherence to this medication is often a struggle for those seeking relief from this debilitating disorder and requires novel approaches to solve the problem. The collaboration between UT Health San Antonio and The University of Texas at San Antonio fosters the amalgamation of two seemingly separate intervention strategies to increase adherence to buprenorphine: mobile technology and behavioral intervention. Upon successful completion of the pilot project, investigators hope to tailor a strategy to combat the opioid epidemic in the United States offering hope to the people and families struggling with opioid use disorder.